Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

DEXCOM INC Director's Dealing 2016

Sep 13, 2016

30198_dirs_2016-09-13_72edce7b-bd76-4043-99ac-d635f692f3ac.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: DEXCOM INC (DXCM)
CIK: 0001093557
Period of Report: 2016-09-09

Reporting Person: MOY JEFFREY (SVP, Operations)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2016-09-09 Common Stock J 8333.0 $95.8 Disposed 68000 Direct
2016-09-09 Common Stock J 6666.0 $95.8 Disposed 61334 Direct
2016-09-09 Common Stock J 8333.0 $95.8 Acquired 52181 Indirect
2016-09-09 Common Stock J 6666.0 $65.8 Acquired 58847 Indirect
2016-09-09 Common Stock D 4445.0 $93.7226 Disposed 54402 Indirect
2016-09-09 Common Stock D 3556.0 $93.7229 Disposed 50846 Indirect

Footnotes

F1: Shares were transferred from direct ownership to ownership under the Moy Family Trust upon vesting of previously awarded restricted stock units.

F2: Included in this number are 61,334 unvested restricted stock units, 33,000 of which were granted on March 8, 2016 and shall vest through March 8, 2019, 20,000 of which were granted on March 8, 2015 and shall vest through March 8, 2018 and 8,334 of which were granted on March 8, 2014 and shall vest through March 08, 2017.

F3: Shares are held by the Moy Family Trust U/A/D 12/09/2013, with respect to which the reporting person is a trustee.

F4: These shares were sold to cover the Company's tax withholding obligation that accrued in connection with the vesting of restricted stock units previously granted.